L303-3210 Screening compound: 1-(4-{5-[(4-chlorophenyl)methyl]-1,2,4-oxadiazol-3-yl}benzenesulfonyl)-4-(pyrrolidine-1-carbonyl)piperidine

L303-3210 Screening compound: 1-(4-{5-[(4-chlorophenyl)methyl]-1,2,4-oxadiazol-3-yl}benzenesulfonyl)-4-(pyrrolidine-1-carbonyl)piperidine
L303-3210 Screening compound: 1-(4-{5-[(4-chlorophenyl)methyl]-1,2,4-oxadiazol-3-yl}benzenesulfonyl)-4-(pyrrolidine-1-carbonyl)piperidine alternative view

Chemical Structure Depiction of ChemDiv screening compound L303-3210
1-(4-{5-[(4-chlorophenyl)methyl]-1,2,4-oxadiazol-3-yl}benzenesulfonyl)-4-(pyrrolidine-1-carbonyl)piperidine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L303-3210

Molecular Formula

C25H27ClN4O4S (C25 H27 ClN4 O4 S)

Compound Name

1-(4-{5-[(4-chlorophenyl)methyl]-1,2,4-oxadiazol-3-yl}benzenesulfonyl)-4-(pyrrolidine-1-carbonyl)piperidine

IUPAC name

1-(4-{5-[(4-chlorophenyl)methyl]-124-oxadiazol-3-yl}benzenesulfonyl)-4-(pyrrolidine-1-carbonyl)piperidine

SMILES

O=C(C(CC1)CCN1S(c(cc1)ccc1-c1noc(Cc(cc2)ccc2Cl)n1)(=O)=O)N1CCCC1

InChI

InChI=1S/C25H27ClN4O4S/c26-21-7-3-18(4-8-21)17-23-27-24(28-34-23)19-5-9-22(10-6-19)35(32,33)30-15-11-20(12-16-30)25(31)29-13-1-2-14-29/h3-10,20H,1-2,11-17H2

InChI Key

ZVNXNLLWIWVQEJ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27243093

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

515.03

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.760

Distribution Coefficient, logD

4.760

Water Solubility, LogSw

-5.07

Polar Surface Area

80.035

Acid Dissociation Constant (pKa)

23.63

Base Dissociation Constant (pKb)

-1.28

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

40.00

L303-3210 in Drug Discovery

Included in Screening Libraries

KRAS-Targeted Library (16000 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Kinases
  • Kinases
  • Phosphatases

References: we are preparing a list of scientific research reports with L303-3210 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L303-3210?
Check Price and Availability of L303-3210, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L303-3210 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L303-3210
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L303-3210
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L303-3210 available by request